Which diabetes-oriented healthcare companies are in the best position to benefit from this global trend? We asked three of our Motley Fool contributors this question, and they picked DexCom, Inc. (NASDAQ: DXCM), Insulet (NASDAQ: PODD), and Tandem Diabetes Care (NASDAQ: TNDM). Here's why these three medtech diabetes companies should be on your radar this month.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,